Literature DB >> 11893080

Joint participation of mitochondria and sarcoplasmic reticulum in the formation of tubular aggregates in gastrocnemius muscle of CK-/- mice.

Marta Novotová1, Ivan Zahradník, Guy Brochier, Michaela Pavlovicová, Xavier Bigard, Renée Ventura-Clapier.   

Abstract

Tubular aggregates are specific subcellular structures that appear in skeletal muscle fibres under different pathological conditions. The origin of the tubular aggregates is generally ascribed to proliferating membranes of sarcoplasmic reticulum. There are, however, histochemical indications for the presence of mitochondrial enzymes in tubular aggregates suggesting contribution of mitochondria to the genesis of tubular aggregates. In this study we used an immunocytochemical detection technique to assess participation of mitochondria and of sarcoplasmic reticulum in derivation of tubular aggregates. The fast skeletal muscle fibres (m. gastrocnemius) of mice bearing the double invalidation for both the mitochondrial and the cytosolic isoforms of creatine kinase (CK), an enzyme involved in energetics of muscle cells, were employed as a model muscle with tubular aggregates (Steeghs et al., Cell 89, 93-103, 1997). Immunogold labelling of the bc1 complex, a specific integral protein of the inner mitochondrial membrane, provided strong signals in both the mitochondria and tubular aggregates but not in other ultrastructural components of muscle fibres. A similar strong immunogold signal was obtained when labelling for SERCA1, a specific enzyme of the sarcoplasmic reticulum membrane, in regions of typical occurrence of the sarcoplasmic reticulum and in tubular aggregates. In double labelling experiments, we found simultaneous labelling of tubular aggregates with both the bc1 and SERCA1 antibodies. It is concluded, that in CK-/- mouse both the inner mitochondrial membrane and the membrane of the sarcoplasmic reticulum participate in the formation of tubular aggregates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893080     DOI: 10.1078/0171-9335-00230

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  6 in total

1.  The extended, dynamic mitochondrial reticulum in skeletal muscle and the creatine kinase (CK)/phosphocreatine (PCr) shuttle are working hand in hand for optimal energy provision.

Authors:  Theo Wallimann
Journal:  J Muscle Res Cell Motil       Date:  2015-10-20       Impact factor: 2.698

2.  Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation.

Authors:  William Schubert; Federica Sotgia; Alex W Cohen; Franco Capozza; Gloria Bonuccelli; Claudio Bruno; Carlo Minetti; Eduardo Bonilla; Salvatore Dimauro; Michael P Lisanti
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse.

Authors:  Yue-Bei Luo; Russell D Johnsen; Lisa Griffiths; Merrilee Needham; Victoria A Fabian; Sue Fletcher; Steve D Wilton; Frank L Mastaglia
Journal:  Int J Exp Pathol       Date:  2013-10-31       Impact factor: 1.925

4.  Sequential stages in the age-dependent gradual formation and accumulation of tubular aggregates in fast twitch muscle fibers: SERCA and calsequestrin involvement.

Authors:  Simona Boncompagni; Feliciano Protasi; Clara Franzini-Armstrong
Journal:  Age (Dordr)       Date:  2011-02-12

5.  Impaired voluntary running capacity of creatine kinase-deficient mice.

Authors:  Iman Momken; Patrick Lechêne; Nathalie Koulmann; Dominique Fortin; Philippe Mateo; Bich Thuy Doan; Jacqueline Hoerter; Xavier Bigard; Vladimir Veksler; Renée Ventura-Clapier
Journal:  J Physiol       Date:  2005-04-14       Impact factor: 5.182

6.  Targeted deletion of the muscular dystrophy gene myotilin does not perturb muscle structure or function in mice.

Authors:  Monica Moza; Luca Mologni; Ras Trokovic; Georgine Faulkner; Juha Partanen; Olli Carpén
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.